MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-MH-26-0252973
Mediblueance Pharmaceuticals LLP
Mediblueance Pharmaceuticals LLP - chemicals in Pune, Maharashtra, India. Directors, charges & compliance details.
Contribution obligation
₹50,000
As per LLP agreement
LLP age
5 yrs
Est. 2021
Designated partners
2
As per MCA filings
Active GSTINs
1
GST registered
Last financials
Mar 2024
Balance sheet date
LLP status
Active
MCA master data
Registrar
Pune
ROC office
Incorporated
11 Feb 2021
Date of incorporation
About Mediblueance Pharmaceuticals LLP
Data last updated:
Mediblueance Pharmaceuticals LLP is a limited liability partnership (LLP) based in Pune, Maharashtra, India. It operates in the chemicals and chemical products segment of the chemicals sector. It was incorporated on 11 February 2021 and has been in existence for over 5 years.
The LLP is registered with the Registrar of Companies (ROC), Pune, under LLPIN AAV-8539. Its GSTIN is 27ABQFM2334N1ZQ (Maharashtra).
The LLP has a total obligation of contribution of ₹50,000. It is led by designated partners Kishor Dattatray Patil and Priya Kishor Patil.
Its latest statement of accounts is for the year ended 31 March 2024. The registered office is at S No. 141 Sai Shrusti Manjari Bk Haveli, Pune, Maharashtra, India – 412307.
Mediblueance Pharmaceuticals LLP is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0252973).
Company details
LLPIN AAV-8539
Incorporation Date 11 February 2021
Total Obligation of Contribution ₹50,000
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2024
MSME Classification Micro
Udyam Registration UDYAM-MH-26-0252973
Recognitions & Rankings of Mediblueance Pharmaceuticals
Contact details
Mediblueance Pharmaceuticals LLP's registered office is in Pune, Maharashtra.
- Registered AddressS No. 141 Sai Shrusti Manjari Bk Haveli, Pune, Maharashtra, India – 412307
- IndustryChemicals, Chemicals and Chemical Products, Manufacturing
Comprehensive company report
Mediblueance Pharmaceuticals LLP - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Mediblueance Pharmaceuticals LLP
FY 2024 filings availableFinancial Statement Summary
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Income and Expenditure | ||||
| Turnover | ||||
| Other Income | ||||
| Total Income | ||||
| Purchases and Direct Costs | ||||
| Personnel Expenses | ||||
| Administrative Expenses | ||||
| Interest | ||||
| Depreciation | ||||
| Total Expenses | ||||
| Profit Before Tax | ||||
| Tax | ||||
| Profit After Tax | ||||
| Profit Transferred to Partners | ||||
| Assets and Liabilities | ||||
| Partners' Contribution | ||||
| Reserves and Surplus | ||||
| Secured Loans | ||||
| Unsecured Loans | ||||
| Trade Payables | ||||
| Other Liabilities and Provisions | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Loans and Advances | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| Net Profit Margin | ||||
| Return on Partners' Funds | ||||
| Return on Assets | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Debt to Partners' Funds | ||||
| Interest Coverage | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Turnover Growth | ||||
| Profit Growth | ||||
To see the full financial statements and ratios of Mediblueance Pharmaceuticals LLP, buy the company report.
Designated partners of Mediblueance Pharmaceuticals LLP
Mediblueance Pharmaceuticals has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
Current Designated Partners
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kishor Dattatray Patil | Designated Partner | 11 Feb 2021 | 5 Years 8 Months | Current |
| Priya Kishor Patil | Designated Partner | 16 Dec 2022 | 3 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Mediblueance Pharmaceuticals LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mediblueance Pharmaceuticals LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mediblueance Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27ABQFM2334N1ZQ | Maharashtra | Active | 13 Aug 2021 |
To see the full GST registrations and return filing status of Mediblueance Pharmaceuticals LLP, buy the company report.
Recent activity
Mediblueance Pharmaceuticals LLP has 3 designated partner changes on record since 2021: 2 appointments and 1 cessation. The latest: Priya Kishor Patil was appointed as Designated Partner on 16 Dec 2022.
AGM
Mediblueance Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Mediblueance Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune.
Appointed
Priya Kishor Patil was appointed as Designated Partner.
Ceased
Shrikant Tanaji Veer ceased to be Designated Partner.
Appointed
Kishor Dattatray Patil was appointed as Designated Partner.
Incorporation
11 Feb 2021
Mediblueance Pharmaceuticals Llp was registered on 11 Feb 2021 with Roc Pune & aged 5 years 8 months as per MCA records.
Frequently asked questions
Mediblueance Pharmaceuticals is an active limited liability partnership based in Pune, Maharashtra, India. The LLP works in chemicals and chemical products, within the chemicals industry. It was incorporated on 11 February 2021 (5+ years old) and is registered under LLPIN AAV-8539.
Mediblueance Pharmaceuticals has 2 current designated partners:
- Kishor Dattatray Patil - Designated Partner
- Priya Kishor Patil - Designated Partner
The latest financial statements of Mediblueance Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Mediblueance Pharmaceuticals is 27ABQFM2334N1ZQ, registered in Maharashtra.
The LLPIN (Limited Liability Partnership Identification Number) of Mediblueance Pharmaceuticals is AAV-8539. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Mediblueance Pharmaceuticals was incorporated on 11 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Pune.
Priya Kishor Patil was appointed as Designated Partner on 16 Dec 2022. Shrikant Tanaji Veer ceased to be Designated Partner on 16 Dec 2022. Kishor Dattatray Patil was appointed as Designated Partner on 11 Feb 2021.
Yes, Mediblueance Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0252973).
The registered office of Mediblueance Pharmaceuticals is at S No. 141 Sai Shrusti Manjari Bk Haveli, Pune, Maharashtra, India – 412307.
Mediblueance Pharmaceuticals operates in the chemicals industry, in the chemicals and chemical products segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages